Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    Open Studies | "Myositis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Environmental Risk Factors for Myositis in Military Personnel
Conditions: Dermatomyositis;   Adult Polymyositis;   Inclusion Body Myositis;   Myositis
Intervention:
2 Recruiting Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies
Conditions: Myositis;   Polymyositis;   Dermatomyositis;   Myositis, Inclusion Body
Intervention: Procedure: MRI-oriented muscle biopsy
3 Recruiting Adult and Juvenile Myositis
Conditions: Dermatomyositis;   Polymyositis;   Inclusion Body Myositis
Intervention:
4 Recruiting Study and Treatment of Inflammatory Muscle Diseases
Conditions: Autoimmune Disease;   Dermatomyositis;   Inclusion Body Myositis;   Myositis;   Polymyositis
Intervention:
5 Recruiting Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
Condition: Sporadic Inclusion Body Myositis (sIBM)
Intervention: Drug: BYM338 (Bimagrumab)
6 Unknown  Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation
Condition: Myositis
Intervention: Other: Physical Exercise
7 Recruiting Exercise in Sjogren and Myositis
Conditions: Primary Sjogren´s Syndrome;   Myositis
Intervention: Other: Exercise training
8 Unknown  Diagnostic Accuracy of MR in Myositis
Conditions: Myositis;   Muscular Disorders, Atrophic
Intervention: Procedure: Magnetic Resonance Imaging
9 Unknown  A Case-control Study to Assess Risk of Coronary Heart Disease in Idiopathic Inflammatory Myopathy
Condition: Idiopathic Inflammatory Myopathy
Intervention:
10 Recruiting Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients
Condition: Sporadic Inclusion Body Myositis
Interventions: Drug: BYM338/bimagrumab;   Drug: Placebo
11 Recruiting Investigating Genes in Patients With Polymyositis and Dermatomyositis
Condition: Myositis
Intervention: Procedure: Venepuncture
12 Unknown  Rituximab-induced Pulmonary Function Changes
Conditions: Rheumatoid Arthritis;   Inflammatory Myositis
Intervention: Other: Lung function measurement
13 Recruiting Environmental Risk Factors for the Anti-synthetase Syndrome
Condition: Myositis
Intervention:
14 Recruiting Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
Conditions: Rheumatic Diseases;   Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Scleroderma;   Dermatomyositis;   Myositis
Intervention:
15 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
16 Not yet recruiting The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
Condition: Juvenile Dermatomyositis
Interventions: Dietary Supplement: Creapure;   Dietary Supplement: Glucose Tablet
17 Recruiting Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
Condition: MYOPATHY
Intervention: Biological: hematopoietic stem cell transplantation
18 Recruiting Skeletal Muscle Inflammation, Oxidative Stress and DNA Repair in Age-Related Sarcopenia
Condition: Sarcopenia
Intervention:
19 Recruiting An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Intervention: Drug: Palovarotene
20 Recruiting An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Interventions: Drug: Palovarotene;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years